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Abstract
The differential diagnosis of a follicular lesion/neoplasm in thyroid FNA specimens includes
hyperplastic/adenomatoid nodule, follicular adenoma and carcinoma, and follicular variant of
papillary thyroid carcinoma. In our laboratory we separate follicular lesions of thyroid into
hyperplastic/adenomatoid nodule (HN), follicular neoplasm (FON) and follicular derived neoplasm
with focal nuclear features suspicious for papillary thyroid carcinoma (FDN).
This study reports our experience with 339 cases diagnosed as FON and 120 as FDN.
All cases were evaluated for histologic diagnosis, age, sex and size of the nodule. Histopathologic
follow-up was available in all cases. The malignancy rate was 22% (74/359) and 72% (86/120) for
cases diagnosed as FON and FDN, respectively. In the FON category almost half of the malignant
cases were papillary carcinoma. The risk of malignancy was higher in patients younger than 40 yr
(53% vs. 30%) than in patients 40 year or more years old and greater in males (41% vs. 33%) than
females. No statistically significant relationship was noted between the sizes of the nodules and
benign vs. malignant diagnosis.
According to this study it is important to divide follicular patterned lesions of thyroid into FON
and FDN in the cytology specimens due to significantly different risk of malignancy (22% vs. 72%).
In addition, clinical features, including gender and age can be part of the decision analysis in selecting
patients for surgery.
Introduction
Fine-needle aspiration (FNA) has been widely accepted as
an initial step in the management of thyroid nodules. It is
relied upon to distinguish benign from neoplastic/malig-
nant thyroid nodules, thus, influencing therapeutic deci-
sions [1,2]. However, the diagnostic efficacy of FNA
declines sharply in the diagnosis of follicular patterned
lesions of thyroid, i.e. separating hyperplastic/adenoma-
toid nodule, follicular adenoma (FA), follicular carci-
noma (FCA) and follicular variant of papillary carcinoma
(FVPTC) [3-5]. Most of these cases are diagnosed as follic-
ular lesion/neoplasm and surgical excision is recom-
mended for definite diagnosis on histopathologic
examination [5,6].
It has been shown that the malignancy rate in cases diag-
nosed as follicular lesion/neoplasm (FON) is approxi-
mately 20% [6-9]. This high rate of benign lesions
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undergoing surgery is because FNA cannot distinguish
between follicular adenoma and carcinoma on the basis
of cyto-morphology [10]. This distinction is made by
demonstrating capsular and/or vascular invasion on his-
topathologic examination [10]. Similarly the cytologic
diagnosis of follicular variant of papillary carcinoma can
be challenging due to overlapping cytologic features, with
both benign and malignant follicular patterned lesions of
the thyroid [11,12]. We have shown in previously pub-
lished studies that these cases can be distinguished from
those diagnosed as follicular neoplasm on the basis of
subtle nuclear changes suggestive of papillary thyroid car-
cinoma [5,11]. We classify such lesions as follicular
derived neoplasm with features suspicious for papillary
carcinoma. The malignancy rate in such lesions is 70–
75% i.e. much higher than seen in cases diagnosed as fol-
licular neoplasm [5].
In this study, we report on our experience with 459 lesions
diagnosed as "follicular neoplasm (FON)" and "follicular
derived neoplasm with features suspicious for papillary
carcinoma (FDN)"; all lesions had histopathologic fol-
low-up.
Materials and methods
At University of Pennsylvania Medical Center (UPMC)
5800 cases underwent ultrasound guided thyroid FNA
from October 1999–May 2005. Three hundred and thirty-
nine cases diagnosed as follicular neoplasm and 120 as
follicular derived neoplasm suspicious for follicular vari-
ant of papillary thyroid carcinoma with histopathologic
follow-up were selected for this study.
All thyroid aspirations were performed under ultrasound
guidance by an endocrinologist and a radiologist. The
FNA was performed using a 25-gauge needle attached to a
10-ml syringe. On average, 2 passes were made in each
nodule, resulting in two air-dried and two alchohol-fixed
smears. Diff-Quik (Harleco, Gibbstown, NJ) stained air-
dried smears were used for on-site evaluation and alcohol-
fixed smears were stained by modified Papanicolaou tech-
nique. The needle was rinsed in Normosol® (Abbott Labo-
ratories, Chicago, IL) for cellblock and Milipore filter
(Millipore, Bedford, MA) preparation.
The adequate FNA specimen was defined as containing at
least 4–6 cell groups on 2 slides, with 10–20 follicular
cells in each group. The cases were diagnosed as FON and
FDN according to previously published criteria.5–6  In
short, the cases diagnosed as FON showed a monotonous
population of follicular cells arranged in cohesive groups
with nuclear overlapping and crowding in a background
of scant colloid. The cases diagnosed as FDN showed fol-
licular cells arranged in loosely cohesive monolayer sheets
Table 1: Malignancy Rates in Cases Diagnosed as FON and FDN
FNA Diagnosis Histopathologic Correlation
BENIGN MALIGNANT
FON (n = 339) 265 (78%) 74 (22%)
FDN (n = 120) 34 (28%) 86 (72%)
Total (n = 459) 299 (65%) 160 (35%)
FON – Follicular neoplasm, FDN-Follicular-derived neoplasm.
Table 2: Histopathologic Correlation in Cases of FON and FDN.
FNA Diagnosis Histologic Diagnosis
NG FA FVPTC PTC FCA HCCA
FON (n = 339) 120 (35%) 145 (43%) 36 (11%) 8 (2%) 21 (6%) 9 (3%)
FDN (n = 120) 24 (20%) 10 (8%) 65 (54%) 14 (12%) 5 (4%) 2 (2%)
Total (n = 459) 144 (31%) 155 (33%) 101 (22%) 22 (5%) 26 (6%) 11 (2.5%)
FDN-follicular-derived neoplasm suspicious for papillary carcinoma, FON-follicular neoplasm, NG-nodular goiter, FA-follicular adenoma, PTC-
classic papillary carcinoma, FVPTC-follicular variant papillary carcinoma, FCA-follicular carcinoma, HCCA-Hürthle cell carcinoma.CytoJournal 2006, 3:9 http://www.cytojournal.com/content/3/1/9
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and follicular groups, focally the cells demonstrated
nuclear elongation, chromatin clearing and intranuclear
grooves in a background of watery and thick colloid. All
patients underwent either lobectomy, or total thyroidec-
tomy with an intraoperative consultation in cases diag-
nosed as FDN on cytology. All demographic data was
obtained from UPMC laboratory information system.
Results
The clinicopathologic and histopathologic features are
illustrated in Tables 1, 2, 3.
The patients ranged in age from 16–87 yr (average age, 52
yr); there were 372 females and 87 males. The size of the
aspirated lesions was determined by the ultrasound and
ranged from 0.6–8.5 cm (average size 2.3 cm, (only one
cystic nodule measured 8.5 cm); 138 nodules were less
than 1.5 cm (only 6 nodules measured less than 1 cm);
232 nodules ranged in size from 1.5–3 cm and, 89 were
greater than 3 cm in size.
Surgical follow-up was available in all cases; 299 cases
(299/459 65%) were classified as benign and 160 (160/
459 35%) as malignant on histologic examination.
Of the 339 cases diagnosed as FON on cytology, histologic
follow-up was benign in 265 (78%) and malignant in 74
(22%) cases. The malignant diagnoses included follicular
variant of papillary carcinoma 36, classic papillary carci-
noma 8, follicular carcinoma 21 and Hurthle cell carci-
noma 9 cases.
Of the 120 cases diagnosed as FDN, the histologic follow-
up was benign in 34(28%) and malignant in 86 (72%)
cases. The malignant diagnoses included FVPTC 65, PTC
14, FCA 5 and Hurthle cell carcinoma 2 cases. Intraopera-
tive consultation was requested in all cases of FDN; 24
cases (30%) were diagnosed as papillary carcinoma on
frozen section and touch preparation.
The average size of the benign nodules was 2.2 cm,
whereas, the average size of classic papillary carcinoma
was 1.7 cm, FVPTC and FCA 2.4 cm and Hurthle cell car-
cinoma 3.4 cm. The rate of malignancy in females was
33% as compared to 41% in males.
Discussion
To date several published series have documented the dif-
ficulty in diagnosing follicular patterned lesions of the
thyroid in cytology preparations [5,13-15]. The histologic
follow-up of cases diagnosed as follicular lesions of neo-
plasm includes hyperplastic/adenomatoid nodules, follic-
ular adenoma, follicular carcinoma and follicular variant
of papillary carcinoma [6,15]. An earlier study published
by Schlinkert et al from Mayo clinic showed that only
12% cases diagnosed as "suspicious for follicular neo-
plasm" on FNA were malignant on histologic follow-up.
Interestingly, 27% were papillary carcinomas (majority
were follicular variant) [4]. Tuttle et al reported malig-
nancy rate of 21% in their series of 149 patients diagnosed
as follicular neoplasm on cytology [8]. In our previous
study the malignancy rate was 31% in 122 patients diag-
nosed as follicular neoplasm and almost half of these
cases were follicular variant of papillary carcinoma.
In view of these above-mentioned studies we retrospec-
tively reviewed the cases of FVPTC and found that some
cases are under-diagnosed as follicular neoplasm due to
the paucity of nuclear features of papillary carcinoma, an
exact reflection of what is seen in surgical pathology of
some cases of FVPTC [3,16]. Similar findings have been
reported by other authors [17-19]. In view of these studies
at our institution the thyroid FNA specimens are classified
as benign, neoplastic, FDN/suspicious for papillary carci-
noma, definitely malignant and non-diagnostic.
In the present study, 339 cases were diagnosed as follicu-
lar neoplasm; the malignancy rate in this group was 22%
and half of the cases were FVPTC. These findings are sim-
ilar to previously published studies. Of the 120 cases diag-
nosed as FDN 72% (86 cases) were malignant and
papillary carcinoma was present in 92% (79/86) of cases.
It has been shown that thyroid nodules can be divided
into high and low risk of malignancy on the basis of clin-
ical characteristics. Schlinkert et al reported that findings
of larger diameter, fixation of mass and younger age of
patients were associated with high risk of malignancy [4].
According to study by Tyler et al patients greater than 50
years of age with a diagnosis of follicular neoplasm had a
higher risk of malignancy as compared to patients
younger than 50 years [9]. In a previous study of 122
patients diagnosed as FON we showed that patients aged
40 years or more had higher risk of malignancy than those
younger than 40 years [6]. Interestingly, the current study
which consists of a much larger group of patients and
combines cases diagnosed as FON and FDN the malig-
nancy rate was higher in patients younger than 40 years
than those aged 40 years or higher (53% vs. 30%). No sig-
nificant difference in malignancy rates was noted between
thyroid nodules measuring less than 3 cm or equal to and
greater than 3 cm. (Fig 1). These differences from the pre-
vious studies could be due to a higher number of cases
diagnosed as papillary carcinomas (>70%) in the present
study. Since, papillary carcinoma is common at younger
age and can occur in any size as compared to follicular or
Hurthle cell carcinoma.
The other significant predictor of malignancy in our study
was sex of patient; malignant tumors were more commonCytoJournal 2006, 3:9 http://www.cytojournal.com/content/3/1/9
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in males as compared to female patients (41% vs. 33%).
In addition, though not statistically significant FCA was
more common in males as compared to females (30% vs.
21%).
Frozen section is usually not recommended for the diag-
nosis of thyroid lesions [20]. Studies have shown that
intraoperative consultation is of no value in the diagnosis
of follicular carcinoma since its diagnosis is dependent
upon invasion of tumor capsule and/or capsular vessels,
which can be missed by limited sampling of tumor cap-
sule on frozen section [20,21]. However, frozen section
combined with intraoperative cytology has been shown to
be of value in cases diagnosed as suspicious of papillary
carcinoma in preventing two-step surgical excision (lobec-
tomy followed by total thyroidectomy)[21]. At our insti-
tution, we recommend intraoperative consultation in
cases diagnosed as FDN on cytology[5]. In the present
study 36(30%) cases were diagnosed as papillary carci-
noma on frozen section and intraoperative cytology.
Diff-Quik® stained smear demonstrating enlarged follicular  cells in loosely cohesive groups (2A) Figure 2
Diff-Quik® stained smear demonstrating enlarged follicular 
cells in loosely cohesive groups (2A). Papanicolaou stained 
slides showing focal nuclear chromatin clearing and intranu-
clear grooves (arrows-Figs 2B-2C). Histologic follow-up 
showing follicular variant of papillary thyroid carcinoma, 
notice the nuclear features on high power (Figs 2D-2E).
Table 3: Clinico-pathologic Features of Cases Diagnosed as FON and FDN on FNA.
FNA Diagnosis Histologic Diagnosis
NG FA FVPTC PTC FCA HCCA
SEX
F e m a l e  ( n  =  3 7 2 ) 1 2 0 1 2 8 8 21 61 88
Male (n = 87) 24 27 19 6 8 3
AGE (ave.: 52 year) 55 yr 53 yr 48 yr 48 yr 49 yr 44 yr
< 45 Yr (n = 126) 25 38 42 10 7 4
45-60 Yr (n = 207) 75 69 38 6 14 5
> 45 Yr (n = 126) 44 48 21 6 5 2
SIZE (ave.: 2.3 cm) 2.2 cm 2.2 cm 2.4 cm 1.7 cm 2.4 cm 3.4 cm
< 1.5 cm (n = 138) 48 48 24 9 7 2
1.5–3 cm (n = 232) 73 78 52 11 13 5
> 3 cm (n = 89) 23 29 25 2 6 4
Total (n = 459) 144 (31%) 155 (33%) 101 (22%) 22 (5%) 26 (6%) 11 (2.5%)
FDN-follicular-derived neoplasm suspicious for papillary carcinoma, FON-follicular neoplasm, NG-nodular goiter, FA-follicular adenoma, PTC-
classic papillary carcinoma, FVPTC-follicular variant PTC, FCA-follicular carcinoma, HCCA-Hürthle cell carcinoma
Monotonous population of follicular cells arranged in cohe- sive follicular groups with nuclear overlapping and crowding,  case diagnosed as follicular neoplasm (1A) Figure 1
Monotonous population of follicular cells arranged in cohe-
sive follicular groups with nuclear overlapping and crowding, 
case diagnosed as follicular neoplasm (1A). Histologic follow-
up showing follicular adenoma (thickly encapsulated follicular 
patterned lesion with no capsular or vascular invasion), the 
inset shows the same nuclear features as seen in cytology 
(1B).CytoJournal 2006, 3:9 http://www.cytojournal.com/content/3/1/9
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It has been shown that molecular markers can be of value
in the cytologic diagnosis of malignant lesions of thyroid.
Ret-oncogene rearrangements are believed to be specific
to papillary carcinoma of the thyroid, and this marker can
be of value in identifying cases of FVPTC in thyroid FNA
[22]. Recently, BRAF rearrangements have been reported
in papillary carcinoma and shown to be specific to this
tumor. Similar studies regarding detection of BRAF rear-
rangements in thyroid FNA specimens have shown prom-
ise as a diagnostic aid to morphology [22,23]. However,
BRAF expression is less common in FVPTC as compared to
classic papillary carcinoma; therefore, its use in the diag-
nosis of FVPTC in FNA specimens may be of limited value.
In conclusion, until a specific markers or panel of markers
is devised which can effectively distinguishes between
benign and malignant follicular lesions of the thyroid in
FNA specimens morphology remains the gold standard.
The category of follicular lesion/neoplasm can further
modified by dividing these cases into two: lesions with
and without subtle nuclear features of papillary carci-
noma because of marked difference in malignancy rates
(22% vs. 72%).
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Correlation between benign and malignant diagnoses, size of  the thyroid nodule, age and sex of the patient Figure 3
Correlation between benign and malignant diagnoses, size of 
the thyroid nodule, age and sex of the patient.
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